BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.28% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.60% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 4.31% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.27% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 4.08% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.82% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 3.55% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.35% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 3.15% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.12% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.92% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 2.75% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.72% |
| CDNS | Cadence Design Systems Inc | Technology | Software - Application | 2.62% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 2.56% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.23% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 1.93% |
| SRT3 | Sartorius Aktiengesellschaft | Healthcare | Medical Instruments & Supplies | 1.87% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 1.85% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 1.85% |